Hofseth BioCare ASA

HBC

NO0010598683

Food Processing

Real-time Oslo Bors Other stock markets 03:23:19 2024-05-28 EDT			5-day change	1st Jan Change
2.05 ^NOK	-4.65%		-4.65%	-21.76%

03-14	Hofseth BioCare ASA Announces Board Changes	CI
02-09	Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Hofseth Biocare ASA Approves Appointment of Christoph Baldegger as New Member of the Audit Committee

November 11, 2020 at 09:03 am

The Board of Directors of Hofseth BioCare ASA has resolved to appoint Christoph Baldegger as new member of the audit committee, and has further resolved to propose that the general meeting of the Company elects a new member to the Board of Directors of the Company.

Latest news about Hofseth BioCare ASA

Hofseth BioCare ASA Announces Board Changes	03-14	CI
Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-09	CI
Hofseth BioCare ASA Reports Earnings Results for the Full Year Ended December 31, 2023	02-09	CI
Hofseth BioCare ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-10	CI
Hofseth BioCare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25	CI
Hofseth BioCare Secures Seed Funding for Pre-clinical Study of Prostate Cancer Treatment	23-08-17	MT
Aqua Bio Technology Asa Announces Distribution Agreement with Hofseth Biocare Asa	23-07-12	CI
Hofseth Biocare ASA Announces the Online Publication of Its Abstract	23-05-29	CI
Norway’s Hofseth Biocare Moves Prostate Cancer Co-treatment Project to US Entity	23-05-15	MT
Hofseth BioCare ASA Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Hofseth BioCare ASA Auditor Raises 'Going Concern' Doubt	23-03-30	CI
Hofseth BioCare ASA Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-10	CI
Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-10	CI
Hofseth BioCare ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
Hofseth BioCare Says Preclinical Trial Shows ProGo Peptides Support Gut Health	22-10-17	MT
Hofseth BioCare ASA's Progo Bioactive Peptides Now Is A "New Dietary Ingredient" for the US FDA	22-08-28	CI
Hofseth BioCare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
Hofseth Biocare Appoints CFO as CEO	22-07-29	MT
Hofseth BioCare ASA Announces Executive Changes	22-07-29	CI
Hofseth BioCare ASA announced that it has received NOK 1.4196 billion in funding	22-06-30	CI
Hofseth BioCare ASA Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-06	CI
Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-04	CI
Hofseth BioCare ASA Approves Election Amy Novogratz to Its Board of Directors	21-12-03	CI
Hofseth Biocare Gets US Dietary Ingredient Status for Nutritional Suplements Extracted from Salmon	21-12-02	MT
Hofseth Biocare ASA Successfully Receive New Dietary Ingredient Status from the US FDA	21-12-01	CI

Chart Hofseth BioCare ASA

Duration

Period

More charts

Company Profile

Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Companyâs business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

Sector

Food Processing

Calendar

2024-08-29 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Food Processing

	1st Jan change	Capi.
HOFSETH BIOCARE ASA	-21.76%	80.94M
NESTLÉ S.A.	-5.40%	265B
MONDELEZ INTERNATIONAL, INC.	-5.70%	91.61B
KRAFT HEINZ	-3.06%	43.53B
DANONE	+0.41%	41.41B
THE HERSHEY COMPANY	+5.66%	39.84B
GENERAL MILLS, INC.	+4.85%	38.56B
ARCHER-DANIELS-MIDLAND COMPANY	-16.24%	29.91B
NESTLÉ INDIA LIMITED	-7.82%	28.53B
ASSOCIATED BRITISH FOODS PLC	+13.86%	25.94B